Showing results (641-650 of 5,983) with videos related to
Sort By:
Pageof 599
Molecular Cancer Therapeutics|June 24, 2004
Involvement of base excision repair in response to therapy targeted at thymidylate synthaseLi Li, Sondra H Berger, Michael D WyattMolecular Cancer Therapeutics|January 7, 2005
Highly efficient delivery of p16 antitumor peptide into aggressive leukemia/lymphoma cells using a novel transporter systemEisaku Kondo, Masao Seto, Kazuhiro Yoshikawa, et al.Molecular Cancer Therapeutics|January 7, 2005
The ex vivo characterization of XR5944 (MLN944) against a panel of human clinical tumor samplesFederica Di Nicolantonio, Louise A Knight, Pauline A Whitehouse, et al.Molecular Cancer Therapeutics|February 17, 2005
Gonadotropin-releasing hormone receptor-targeted gene therapy of gynecologic cancersCarsten Gründker, Abdohamid Huschmand Nia, Günter EmonsMolecular Cancer Therapeutics|February 17, 2005
Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survivalRubén W Carón, Adly Yacoub, Min Li, et al.Molecular Cancer Therapeutics|February 17, 2005
Phosphorothioate oligodeoxynucleotides and G3139 induce apoptosis in 518A2 melanoma cellsJohnathan C Lai, Luba Benimetskaya, Anastasia Khvorova, et al.Molecular Cancer Therapeutics|February 17, 2005
Marine natural products as anticancer drugsT Luke Simmons, Eric Andrianasolo, Kerry McPhail, et al.Molecular Cancer Therapeutics|July 16, 2005
The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growthMary Ann Jordan, Kathryn Kamath, Tapas Manna, et al.Molecular Cancer Therapeutics|July 16, 2005
Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xLJoshua A Bauer, Douglas K Trask, Bhavna Kumar, et al.Molecular Cancer Therapeutics|July 16, 2005
Discovery and preclinical evaluation of a novel class of small-molecule compounds in hormone-dependent and -independent cancer cell linesCarmen Plasencia, Raveendra Dayam, Qingcai Wang, et al.Pageof 599